BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

535 related articles for article (PubMed ID: 16978839)

  • 1. Neuregulin-1 only induces trans-phosphorylation between ErbB receptor heterodimer partners.
    Li Z; Mei Y; Liu X; Zhou M
    Cell Signal; 2007 Mar; 19(3):466-71. PubMed ID: 16978839
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression, localization, and regulation of the neuregulin receptor ErbB3 in mouse heart.
    Campreciós G; Lorita J; Pardina E; Peinado-Onsurbe J; Soley M; Ramírez I
    J Cell Physiol; 2011 Feb; 226(2):450-5. PubMed ID: 20672328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Widespread expression of ErbB2, ErbB3 and ErbB4 in non-human primate brain.
    Thompson M; Lauderdale S; Webster MJ; Chong VZ; McClintock B; Saunders R; Weickert CS
    Brain Res; 2007 Mar; 1139():95-109. PubMed ID: 17280647
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neuregulin-I/ErbB signaling system in development and disease.
    Britsch S
    Adv Anat Embryol Cell Biol; 2007; 190():1-65. PubMed ID: 17432114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. c-Src modulates ErbB2 and ErbB3 heterocomplex formation and function.
    Ishizawar RC; Miyake T; Parsons SJ
    Oncogene; 2007 May; 26(24):3503-10. PubMed ID: 17173075
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Growth stimulation of non-small cell lung cancer cell lines by antibody against epidermal growth factor receptor promoting formation of ErbB2/ErbB3 heterodimers.
    Maegawa M; Takeuchi K; Funakoshi E; Kawasaki K; Nishio K; Shimizu N; Ito F
    Mol Cancer Res; 2007 Apr; 5(4):393-401. PubMed ID: 17426253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Compensatory ErbB3/c-Src signaling enhances carcinoma cell survival to ionizing radiation.
    Contessa JN; Abell A; Mikkelsen RB; Valerie K; Schmidt-Ullrich RK
    Breast Cancer Res Treat; 2006 Jan; 95(1):17-27. PubMed ID: 16267617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of epidermal growth factor receptor or ErbB3 facilitates geldanamycin-induced down-regulation of ErbB2.
    Pedersen NM; Breen K; Rødland MS; Haslekås C; Stang E; Madshus IH
    Mol Cancer Res; 2009 Feb; 7(2):275-84. PubMed ID: 19208749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Constitutive activation of the neuregulin-1/ErbB receptor signaling pathway is essential for the proliferation of a neoplastic Schwann cell line.
    Frohnert PW; Stonecypher MS; Carroll SL
    Glia; 2003 Aug; 43(2):104-18. PubMed ID: 12838503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ErbB2 and ErbB3 do not quantitatively modulate ligand-induced ErbB4 tyrosine phosphorylation.
    Feroz K; Williams E; Riese DJ
    Cell Signal; 2002 Sep; 14(9):793-8. PubMed ID: 12034361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A naturally occurring secreted human ErbB3 receptor isoform inhibits heregulin-stimulated activation of ErbB2, ErbB3, and ErbB4.
    Lee H; Akita RW; Sliwkowski MX; Maihle NJ
    Cancer Res; 2001 Jun; 61(11):4467-73. PubMed ID: 11389077
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Asn418-linked N-glycan of ErbB3 plays a crucial role in preventing spontaneous heterodimerization and tumor promotion.
    Yokoe S; Takahashi M; Asahi M; Lee SH; Li W; Osumi D; Miyoshi E; Taniguchi N
    Cancer Res; 2007 Mar; 67(5):1935-42. PubMed ID: 17332320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of patients with transitional cell carcinoma of the bladder overexpressing ErbB2, ErbB3, or specific ErbB4 isoforms: real-time reverse transcription-PCR analysis in estimation of ErbB receptor status from cancer patients.
    Junttila TT; Laato M; Vahlberg T; Söderström KO; Visakorpi T; Isola J; Elenius K
    Clin Cancer Res; 2003 Nov; 9(14):5346-57. PubMed ID: 14614020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of ErbB3, ErbB4, and neuregulin-1 mRNA during tooth development.
    Fried K; Risling M; Tidcombe H; Gassmann M; Lillesaar C
    Dev Dyn; 2002 Jul; 224(3):356-60. PubMed ID: 12112465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ligands for ErbB-family receptors encoded by a neuregulin-like gene.
    Chang H; Riese DJ; Gilbert W; Stern DF; McMahan UJ
    Nature; 1997 May; 387(6632):509-12. PubMed ID: 9168114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced drug resistance in cells coexpressing ErbB2 with EGF receptor or ErbB3.
    Chen X; Yeung TK; Wang Z
    Biochem Biophys Res Commun; 2000 Nov; 277(3):757-63. PubMed ID: 11062025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective hormone-dependent repression of estrogen receptor beta by a p38-activated ErbB2/ErbB3 pathway.
    St-Laurent V; Sanchez M; Charbonneau C; Tremblay A
    J Steroid Biochem Mol Biol; 2005 Feb; 94(1-3):23-37. PubMed ID: 15862947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuregulin induces the rapid association of focal adhesion kinase with the erbB2-erbB3 receptor complex in schwann cells.
    Vartanian T; Goodearl A; Lefebvre S; Park SK; Fischbach G
    Biochem Biophys Res Commun; 2000 May; 271(2):414-7. PubMed ID: 10799311
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of the EGF receptor family members ErbB2, ErbB3, and ErbB4 in germinal zones of the developing brain and in neurosphere cultures containing CNS stem cells.
    Kornblum HI; Yanni DS; Easterday MC; Seroogy KB
    Dev Neurosci; 2000; 22(1-2):16-24. PubMed ID: 10657694
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Truncated ErbB2 receptor (p95ErbB2) is regulated by heregulin through heterodimer formation with ErbB3 yet remains sensitive to the dual EGFR/ErbB2 kinase inhibitor GW572016.
    Xia W; Liu LH; Ho P; Spector NL
    Oncogene; 2004 Jan; 23(3):646-53. PubMed ID: 14737100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.